Page last updated: 2024-12-06

dimethylamphetamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID20006
CHEBI ID173436
SCHEMBL ID727641
MeSH IDM0044797

Synonyms (45)

Synonym
4075-96-1
n,n-dimethyl-1-phenylpropan-2-amine
CHEBI:173436
benzeneethanamine, n,n,.alpha.-trimethyl-
phenethylamine, n,n,.alpha.-trimethyl-
NCIOPEN2_000819
dimethylamphetamine
alpha-phenyl-beta-dimethyl amino propane
brn 1938312
phenethylamine, n,n,alpha-trimethyl-
n,n,alpha-trimethylbenzeneethanamine
1-phenyl-2-dimethylamino-propan [german]
2-dimethylamino-1-phenylpropane
1-phenyl-2-dimethylaminopropane
benzeneethanamine, n,n,alpha-trimethyl-
n,n,alpha-trimethylphenethylamine
NCGC00160430-01
STK664810
n,n-dimethylamphetamine
49681-82-5
AKOS005536002
dea no. 1480
1-phenyl-2-dimethylamino-propan
(+-)-n,n-dimethylamphetamine
dimethylpropamine
unii-iye3f3mhcu
iye3f3mhcu ,
SI38000500
(+-)-n,n,alpha-trimethylphenethylamine
niosh/si3800050
phenethylamine, n,n,alpha-trimethyl-, (+-)-
dl-1-phenyl-2-dimethylaminopropane
SCHEMBL727641
AB01326568-02
OBDSVYOSYSKVMX-UHFFFAOYSA-N
J14.522J ,
(+/-)-dimethylamphetamine
(+/-)-n,n-dimethylamphetamine
dimethyl(1-phenylpropan-2-yl)amine
alpha-phenyl-beta-dimethylaminopropane
n,n,alpha-trimethyl-phenethylamine
NCGC00160430-02
DTXSID40860201
Q27280952
n,n-dma (hydrochloride)

Research Excerpts

Overview

N,N-dimethylamphetamine (DMA) is a methamphetamine analogue known to be a weaker central nervous system stimulant than methamphetamine.

ExcerptReferenceRelevance
"N,N-dimethylamphetamine (DMA) is a methamphetamine analogue known to be a weaker central nervous system stimulant than methamphetamine. "( Flavin-containing monooxygenase 1-catalysed N,N-dimethylamphetamine N-oxidation.
In, MK; Jin, C; Kang, MJ; Kim, DH; Lee, SK; Yoo, HH, 2009
)
1.17
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amphetaminesAmines that constitute a class of central nervous system stimulants based on the structure of the parent amphetamine 1-phenylpropan-2-amine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (46.43)18.7374
1990's4 (14.29)18.2507
2000's7 (25.00)29.6817
2010's4 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.21 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.03%)5.53%
Reviews1 (3.03%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (93.94%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]